Screener
Spyre Therapeutics, Inc. SYRE Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Spyre Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Spyre Therapeutics, Inc.’s 10-Q, filed May 8, 2025. Open the filing →
- Filed
- May 8, 2025
- Fiscal quarter
- Q1 FY2025
- Calendar quarter
- Q1 2025
- Accession
- 0001636282-25-000049
FAQ
- What is Spyre Therapeutics, Inc.'s price / sales?
- Spyre Therapeutics, Inc. (SYRE) reported price / sales of 1,993× in Q1 2024.
- How has Spyre Therapeutics, Inc.'s price / sales changed year-over-year?
- Spyre Therapeutics, Inc.'s price / sales increased by 8393.8% year-over-year, from 23.5× to 1,993×.
- What is the long-term trend for Spyre Therapeutics, Inc.'s price / sales?
- Over 2 years (2021 to 2023), Spyre Therapeutics, Inc.'s price / sales has grown at a 623.2% compound annual growth rate (CAGR), from 16.7× to 874.9×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Spyre Therapeutics, Inc.'s price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude